Stock listing
A2PP89 Stock Price, News, Filings & Events — Lineage Cell Therapeutics, Inc.
Selected listing: A2PP89 · LSX · EUR · DE
This page tracks Lineage Cell Therapeutics, Inc.'s A2PP89:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PP89:LSX. A2PP89:LSX is the stock-level entry point for investors researching Lineage Cell Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lineage Cell Therapeutics, Inc. (ticker: LCTX) is a public company based in the United States, focused on developing innovative cell therapies. With a market capitalization of approximately $256.8 million, Lineage is dedicated to advancing treatments for various medical conditions through its proprietary technologies. The company aims to improve patient outcomes by leveraging its expertise in regenerative medicine.
- Ticker
- A2PP89:LSX
- Asset type
- Stock
- Market cap
- $280.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSX
- Currency
- EUR
Lineage Cell Therapeutics, Inc. A2PP89:LSX stock context
This page tracks Lineage Cell Therapeutics, Inc.'s A2PP89:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PP89:LSX. A2PP89:LSX is the stock-level entry point for investors researching Lineage Cell Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lineage Cell Therapeutics, Inc. (ticker: LCTX) is a public company based in the United States, focused on developing innovative cell therapies. With a market capitalization of approximately $256.8 million, Lineage is dedicated to advancing treatments for various medical conditions through its proprietary technologies. The company aims to improve patient outcomes by leveraging its expertise in regenerative medicine.
Latest news from Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026
Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026
May 5, 2026
OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026
May 4, 2026
Lineage Announces Formation of Scientific Advisory Board
April 13, 2026
Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease
March 24, 2026
Lineage Cell Therapeutics, Inc. earnings calls
Lineage Cell Therapeutics, Inc. (LCTX) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Lineage Cell Therapeutics, Inc. (LCTX) Q1 2026 Earnings Call
May 12, 2026 · Replay with transcript and chapters
Lineage Cell Therapeutics, Inc. (LCTX) Q4 2025 Earnings Call
March 5, 2026 · Replay with transcript and chapters
Lineage Cell Therapeutics, Inc. (LCTX) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Lineage Cell Therapeutics, Inc. (LCTX) Q2 2025 Earnings Call
August 12, 2025 · Replay with transcript and chapters
Lineage Cell Therapeutics, Inc. (LCTX) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Research Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A2PP89:LSX.
Lineage Cell Therapeutics, Inc. company profile
View the public company page for Lineage Cell Therapeutics, Inc. on 6ix.
Lineage Cell Therapeutics, Inc. news
Read company news and market updates connected to Lineage Cell Therapeutics, Inc..
Lineage Cell Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Lineage Cell Therapeutics, Inc..
Alternate listings
LCTX:AMEX
US · USD
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is A2PP89:LSX.
LCTX:TASE
IL · ILA
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is A2PP89:LSX.
BT3:GETTEX
DE · EUR
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is A2PP89:LSX.
A2PP89:LS
DE · EUR
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is A2PP89:LSX.
LCTX:BOATS
US · USD
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is A2PP89:LSX.
BT3:FWB
DE · EUR
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is A2PP89:LSX.
BT3:TRADEGATE
DE · EUR
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is A2PP89:LSX.
BT3:DUS
DE · EUR
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is A2PP89:LSX.
BT3:SWB
DE · EUR
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is A2PP89:LSX.